MapLight Therapeutics, Inc. (MPLT) Deferred Tax Assets and Other Non-Current Assets — Quarterly & Annual

Screener

Deferred Tax Assets and Other Non-Current Assets at other companies

Acadia PharmaceuticalsACAD

$3.55M+57.6%

Rapport Therapeutics, Inc.RAPP

$1.06M+2.2%

Praxis Precision Medicines, Inc.PRAX

$643K—

Bristol-Myers SquibbBMY

——

Neurocrine BiosciencesNBIX

——

AbbVieABBV

——

Other financials

Income statement

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

Market cap$551.86M-20.4%

Enterprise value$501.74M—

Returns & leverage

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026.

Filed: May 14, 2026, 4:25 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001193125-26-224129

Line item	March 31, 2026	December 31, 2025
Long-term investments	85,090	147,993
Restricted cash	207	207
Right-of-use asset	5,259	5,488
Other assets	36	59
Total assets	$418,788	$479,512
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$3,188	$3,289

Item 1. Financial Statements.

FAQ

What is MapLight Therapeutics, Inc.'s deferred tax assets and other non-current assets?: MapLight Therapeutics, Inc. (MPLT) reported deferred tax assets and other non-current assets of $36K in Q1 2026.

Ask your AI about MapLight Therapeutics, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk